Evidence map›Paper›PMID 32493194›Full record

ArticleCurrent topics in medicinal chemistry2020

Learning the Edit Costs of Graph Edit Distance Applied to Ligand-Based Virtual Screening.

Carlos Garcia-Hernandez, Alberto Fernández, Francesc Serratosa

Abstract read
In one paragraph

Article in Current topics in medicinal chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Ligand-Based Virtual Screening Based on the Graph Edit Distance.International journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carlos Garcia-HernandezDepartment of Chemical Engineering, Rovira i Virgili University, Tarragona, Spain.
Alberto FernándezDepartment of Chemical Engineering, Rovira i Virgili University, Tarragona, Spain.
Francesc SerratosaDepartment of Computer Engineering and Mathematics, Rovira i Virgili University, Tarragona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGraph edit distance is a methodology used to solve error-tolerant graph matching. This methodology estimates a distance between two graphs by determining the minimum number of modifications required to transform one graph into the other. These modifications, known as edit operations, have an edit cost associated that has to be determined depending on the problem.

objectiveThis study focuses on the use of optimization techniques in order to learn the edit costs used when comparing graphs by means of the graph edit distance.

methodsGraphs represent reduced structural representations of molecules using pharmacophore-type node descriptions to encode the relevant molecular properties. This reduction technique is known as extended reduced graphs. The screening and statistical tools available on the ligand-based virtual screening benchmarking platform and the RDKit were used.

resultsIn the experiments, the graph edit distance using learned costs performed better or equally good than using predefined costs. This is exemplified with six publicly available datasets: DUD-E, MUV, GLL&GDD, CAPST, NRLiSt BDB, and ULS-UDS.

conclusionThis study shows that the graph edit distance along with learned edit costs is useful to identify bioactivity similarities in a structurally diverse group of molecules. Furthermore, the target-specific edit costs might provide useful structure-activity information for future drug-design efforts.

Indexed as

LearningComputer GraphicsDatabases, FactualDrug Evaluation, PreclinicalLigandsLigandsExtended reduced graphGraph edit distanceMachine learningMolecular similarityStructure-activity relationshipsVirtual screening

Identifiers

PMID32493194
PMCPMC7536799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.